 
| In ZINC since | Heavy atoms | Benign functionality | 
|---|---|---|
| June 23rd, 2008 | 32 | Yes | 
Popular Name: 4-(4-(3-(Pyridin-2-yl)-1H-pyrazol-4-yl)pyridin-2-yl)-N-(tetrahydro-2H-pyran-4-yl)benzamide 4-(4-(3-(Pyridin-2-yl)-1H-pyrazo…
Find On: PubMed — Wikipedia — Google
CAS Numbers: 452342-67-5 , [452342-67-5]
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL | 
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 2.74 | 8.04 | -17.99 | 2 | 7 | 0 | 93 | 425.492 | 5 | ↓ | 
| Ref Reference (pH 7) | 2.74 | 8.04 | -14.3 | 2 | 7 | 0 | 93 | 425.492 | 5 | ↓ | 
| Lo Low (pH 4.5-6) | 2.74 | 8.24 | -41.61 | 3 | 7 | 1 | 94 | 426.5 | 5 | ↓ | 
| Note Type | Comments | Provided By | 
|---|---|---|
| Target | TGF-beta/Smad | Selleck Chemicals | 
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type | 
|---|---|---|---|---|---|
| MK14-1-E | MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic | Eukaryotes | 7280 | 0.22 | Binding ≤ 10μM | 
| TGFB1-1-E | Transforming Growth Factor Beta-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 446 | 0.28 | Binding ≤ 10μM | 
| TGFR1-1-E | TGF-beta Receptor Type I (cluster #1 Of 1), Eukaryotic | Eukaryotes | 18 | 0.34 | Binding ≤ 10μM | 
| Z81020-4-O | HepG2 (Hepatoblastoma Cells) (cluster #4 Of 8), Other | Other | 93 | 0.31 | Functional ≤ 10μM | 
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type | 
|---|---|---|---|---|---|
| TGFR1_HUMAN | P36897 | TGF-beta Receptor Type I, Human | 18 | 0.34 | Binding ≤ 1μM | 
| TGFB1_HUMAN | P01137 | Transforming Growth Factor Beta-1, Human | 446 | 0.28 | Binding ≤ 1μM | 
| MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 7280 | 0.22 | Binding ≤ 10μM | 
| TGFR1_HUMAN | P36897 | TGF-beta Receptor Type I, Human | 18 | 0.34 | Binding ≤ 10μM | 
| TGFB1_HUMAN | P01137 | Transforming Growth Factor Beta-1, Human | 446 | 0.28 | Binding ≤ 10μM | 
| Z81020 | Z81020 | HepG2 (Hepatoblastoma Cells) | 93 | 0.31 | Functional ≤ 10μM | 
| Description | Species | 
|---|---|
| activated TAK1 mediates p38 MAPK activation | |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | |
| Activation of the AP-1 family of transcription factors | |
| ADP signalling through P2Y purinoceptor 1 | |
| CDO in myogenesis | |
| Downregulation of TGF-beta receptor signaling | |
| DSCAM interactions | |
| ECM proteoglycans | |
| ERK/MAPK targets | |
| Influenza Virus Induced Apoptosis | |
| KSRP destabilizes mRNA | |
| Molecules associated with elastic fibres | |
| NOD1/2 Signaling Pathway | |
| Oxidative Stress Induced Senescence | |
| p38MAPK events | |
| Platelet degranulation | |
| Platelet sensitization by LDL | |
| SMAD2/3 MH2 Domain Mutants in Cancer | |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | |
| Syndecan interactions | |
| TGF-beta receptor signaling activates SMADs | |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | |
| TGFBR1 KD Mutants in Cancer | |
| TGFBR1 LBD Mutants in Cancer | |
| TGFBR2 Kinase Domain Mutants in Cancer | |
| TGFBR2 MSI Frameshift Mutants in Cancer | |
| Transcriptional regulation of white adipocyte differentiation | |
| VEGFA-VEGFR2 Pathway | 
No pre-computed analogs available. Try a structural similarity search.